Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: Adherence to Dolutegravir and Outcome

View source ↗

Summary

A clinical trial update about adherence to dolutegravir and patient outcomes in HIV, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tivicay (dolutegravir)

Snippet

Sponsor: University Hospital, Caen | Conditions: HIV | Status: UNKNOWN